Mannkind (MNKD) Net Cash Flow (QoQ) (2010 - 2026)
Mannkind (MNKD) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Mannkind |
1.13 Bn |
995.19 Mn |
82.66 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
58.01% |
| Dec 31, 2025 |
-174.60% |
| Sep 30, 2025 |
625.95% |
| Jun 30, 2025 |
894.46% |
| Mar 31, 2025 |
106.08% |
| Dec 31, 2024 |
53.21% |
| Sep 30, 2024 |
64.27% |
| Jun 30, 2024 |
-112.12% |
| Mar 31, 2024 |
-129.08% |
| Dec 31, 2023 |
5,007.32% |
| Sep 30, 2023 |
-1,105.71% |
| Jun 30, 2023 |
-98.04% |
| Mar 31, 2023 |
4.16% |
| Dec 31, 2022 |
-17.78% |
| Sep 30, 2022 |
159.24% |
| Jun 30, 2022 |
44.27% |
| Mar 31, 2022 |
-178.60% |
| Dec 31, 2021 |
771.90% |
| Sep 30, 2021 |
94.19% |
| Jun 30, 2021 |
-202.57% |
